| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Skorpios Trust is a 10% Owner at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $128.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | STOK Stoke Therapeutics, Inc. | 10% Owner | Sell | 3,000,000 | $10.20 | $30,600,000.00 | -43.4% | +79.1% | - | |
| Dec 23, 2024 | STOK Stoke Therapeutics, Inc. | 10% Owner | Sell | 2,000,000 | $11.50 | $23,000,000.00 | -22.5% | -28.6% | +174.4% | |
| Sep 19, 2024 | STOK Stoke Therapeutics, Inc. | 10% Owner | Sell | 1,937,500 | $14.05 | $27,221,875.00 | -17.9% | -26.6% | +51.3% | |
| Apr 17, 2024 | STOK Stoke Therapeutics, Inc. | 10% Owner | Sell | 3,600,000 | $11.60 | $41,760,000.00 | -24.9% | +25.8% | -34.4% |